Faculty

Institution

Unit

Venue

Robert Dood

Assistant Professor

University of Utah

Affiliations

School of Medicine

Department of Obstetrics and Gynecology

Division of Gynecologic Oncology

Robert Dood is currently serving as an Obstetrics And Gynecology Assistant Professor at University of Utah.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Robert Dood

University of Utah

Assistant Professor

You can click a keyword to filter the displayed items

oncology gynecologic oncology gynecology cancer research ovarian cancer cancer treatment cancer biology pharmacology tumor microenvironment pathology tumor biology endometrial cancer survival analysis medicinal research oncogenes cancer care cancer management anti-vegf therapy macrophage depletion neuroscience recovery vascular biology cancer cells obstetrics and gynaecology surgical oncology cancer genetics metastasis autophagy jama oncology molecular diagnostics enzyme inhibition clinical investigation crisis management death studies phytotherapy research hemostasis blood platelet graft rejection graft survival immune dysregulation therapy resistance novel therapies tumor heterogeneity variant interpretation recombination dynamic pathway analysis angiogenesis signaling pathways neovascularization obstetrics incident investigation laparoscopy oncogenic agent anti-cancer agents tumor targeting diagnostic tests evidence-based medicine evidence-based interventions evidence-based practice gynecological surgery cancer genomics medical genetics molecular analysis bdnf induction survivorship trajectories solid tumors clinical significance pathway inhibition tumor core biopsies immune microenvironment high-grade serous carcinoma antihypertensive medication use ovarian cancer survival urinary injury placenta accreta spectrum surgery implementation science enhanced recovery outcomes research clinical endpoint

Notable Scholarly Works

Notable Federal Grants

Collaborators

Clinical Trial Enrollment During First Course of Gynecologic Cancer Treatment and Survival. Gynecologic Oncology (2024)

Wafa KhadraouiJennifer A SinnottCaitlin E MeadeJesse PlascakAutumn CareyFloor J BackesRobert L DoodBritton TrabertAshley S Felix

gynecologic oncologygynecologic cancer treatmentgynecologyfirst coursegynecologic cancersclinical researchcancer treatmentclinical trialsoncologyclinical trial enrollment

Comparison of the Clinical and Genomic Profiles of Endometrial Cancer in Appalachian and Non-Appalachian Patients.. Journal of Clinical Oncology (2024)

Taylor A RivesAbu Saleh Mosa FaisalJinpeng LiuHye Sook ChonCasey CosgroveBradley CorrRobert DoodStephen B. EdgeAliza L. LeiserChristina WashingtonBodour SalhiaChris MoskalukNeil T. PhippenLisa Michelle LandrumDava West PiecoroMichelle ChurchmanCharles S DietrichFrederick R UelandChi WangJill Kolesar

gynecologic oncologynon-appalachian patientsgenomic profilesgynecologyendometrial cancerclinical researchovarian canceroncology

Increased Incidence of Dach1 Mutation in Appalachian Women With Uterine Cancer and Altered Chemotherapy Sensitivity. Research Square (2023)

McKayla RiggsNan LinKristen HillGuogen MaoBreanna KnicelyDava PiecoroBryan P. SchneiderHye ChonJohn D. CarptenMichelle ChurchmanBradley CorrChristina WashingtonRobert DoodStephen EdgeAliza LeiserErin SiegelFrederick UelandRachel MillerEva GoellnerJill Kolesar

appalachian womenuterine cancerwomen's healthcancer researchchemotherapy sensitivitygeneticsgenetic epidemiologycancer geneticsoncologystatistics

Dach1 Mutation Frequency in Endometrial Cancer is Associated With High Tumor Mutation Burden in a Nationwide Cohort.. Journal of Clinical Oncology (2022)

McKayla J RiggsNan LinRachel W. MillerDava West PiecoroBryan P. SchneiderHye Sook ChonJohn D. CarptenMichelle L. ChurchmanBradley CorrChristina WashingtonRobert DoodStephen B. EdgeAliza L. LeiserErin M. SiegelFrederick West UelandJill Kolesar

gynecologic oncologynationwide cohortepidemiologycancer biologygynecologycancer researchmedical geneticsendometrial cancerclinical researchcancer geneticscancer genomicsoncologygenetics

Misdiagnosed and Over- or Undertreated? Patients With Synchronous Ovarian and Uterine Cancers Outperform Those With Single Primaries (493). Gynecologic Oncology (2022)

Chelsey VranesJennifer DohertyLisa PappasLindsay CollinBritton TrabertRobert Dood

gynecologic oncologydiagnosisgynecologyovarian cancercancer treatmentoncologysingle primaries

Mortality Patterns of Synchronous Uterine and Ovarian Cancers: A Seer Registry Analysis. Cancer Epidemiology Biomarkers & Prevention (2022)

Robert Lee DoodLisa M. PappasLindsay J. CollinChelsey VranesBritton TrabertJennifer Anne Doherty

biostatisticspublic healthseer registry analysismortality patternsovarian cancersynchronous uterinehealth sciencesoncology

Prophylactic Ureteral Stent Placement and Urinary Injury During Hysterectomy for Placenta Accreta Spectrum. Obstetrics and Gynecology (2022)

Morgan A. ScaglioneAmanda A. AllshouseDana R. CanfieldHannah D. MclaughlinAnn M. BrunoIbrahim A. HammadD. Ware BranchKathryn A. MaurerRobert L. DoodMichelle P. DebbinkRobert M. SilverBrett D. Einerson

urinary injuryplacenta accreta spectrumgynecologyobstetrics and gynaecologyurologymaternal healthobstetrics

The Time is Now to Start Molecular Subtyping High-Intermediate and High-Risk Endometrial Cancers. International Journal of Gynecological Cancer (2022)

Robert DoodBritton TrabertTheresa L WernerDavid GaffneyElke Jarboe

gynecologic oncologygynecologycancer researchoncologycancer biologyobstetrics and gynaecology

Antihypertensive Medication Use and Ovarian Cancer Survival. Gynecologic Oncology (2021)

Tianyi HuangMary K. TownsendRobert L. DoodAnil K. SoodShelley S. Tworoger

gynecologic oncologyantihypertensive medication usemedicinepharmacologyovarian cancerovarian cancer survival

Clinical Significance of Homologous Recombination Deficiency Score Testing in Endometrial Cancer. Gynecologic Oncology (2021)

Jean H. SiedelKari L. RingWei HuRobert L. DoodYing WangKeith BaggerlyKathleen M. DarcyThomas P. ConradsShannon GallagherPlacede TshiabaChris NeffKirsten M. TimmsSelanere MangalaShannon N. WestinRussell BroaddusGabriel Lopez-BeresteinKaren H. LuRobert L. ColemanGeorge L. MaxwellAnil K. Sood

gynecologic oncologypathologyrecombination dynamicvariant interpretationgynecologyclinical significancecancer researchmolecular diagnosticsendometrial cancergynecologic cancersoncology

1
2
3
4
10 / page

Robert Dood

Assistant Professor

University of Utah

Affiliations

School of Medicine

Department of Obstetrics and Gynecology

Division of Gynecologic Oncology

Robert Dood is currently serving as an Obstetrics And Gynecology Assistant Professor at University of Utah.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Robert Dood

University of Utah

Assistant Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Clinical Trial Enrollment During First Course of Gynecologic Cancer Treatment and Survival. Gynecologic Oncology (2024)

Wafa KhadraouiJennifer A SinnottCaitlin E MeadeJesse PlascakAutumn CareyFloor J BackesRobert L DoodBritton TrabertAshley S Felix

gynecologic oncologygynecologic cancer treatmentgynecologyfirst coursegynecologic cancersclinical researchcancer treatmentclinical trialsoncologyclinical trial enrollment

Comparison of the Clinical and Genomic Profiles of Endometrial Cancer in Appalachian and Non-Appalachian Patients.. Journal of Clinical Oncology (2024)

gynecologic oncologynon-appalachian patientsgenomic profilesgynecologyendometrial cancerclinical researchovarian canceroncology

Increased Incidence of Dach1 Mutation in Appalachian Women With Uterine Cancer and Altered Chemotherapy Sensitivity. Research Square (2023)

appalachian womenuterine cancerwomen's healthcancer researchchemotherapy sensitivitygeneticsgenetic epidemiologycancer geneticsoncologystatistics

Dach1 Mutation Frequency in Endometrial Cancer is Associated With High Tumor Mutation Burden in a Nationwide Cohort.. Journal of Clinical Oncology (2022)

gynecologic oncologynationwide cohortepidemiologycancer biologygynecologycancer researchmedical geneticsendometrial cancerclinical researchcancer geneticscancer genomicsoncologygenetics

Misdiagnosed and Over- or Undertreated? Patients With Synchronous Ovarian and Uterine Cancers Outperform Those With Single Primaries (493). Gynecologic Oncology (2022)

Chelsey VranesJennifer DohertyLisa PappasLindsay CollinBritton TrabertRobert Dood

gynecologic oncologydiagnosisgynecologyovarian cancercancer treatmentoncologysingle primaries

Mortality Patterns of Synchronous Uterine and Ovarian Cancers: A Seer Registry Analysis. Cancer Epidemiology Biomarkers & Prevention (2022)

Robert Lee DoodLisa M. PappasLindsay J. CollinChelsey VranesBritton TrabertJennifer Anne Doherty

biostatisticspublic healthseer registry analysismortality patternsovarian cancersynchronous uterinehealth sciencesoncology

Prophylactic Ureteral Stent Placement and Urinary Injury During Hysterectomy for Placenta Accreta Spectrum. Obstetrics and Gynecology (2022)

urinary injuryplacenta accreta spectrumgynecologyobstetrics and gynaecologyurologymaternal healthobstetrics

The Time is Now to Start Molecular Subtyping High-Intermediate and High-Risk Endometrial Cancers. International Journal of Gynecological Cancer (2022)

Robert DoodBritton TrabertTheresa L WernerDavid GaffneyElke Jarboe

gynecologic oncologygynecologycancer researchoncologycancer biologyobstetrics and gynaecology

Antihypertensive Medication Use and Ovarian Cancer Survival. Gynecologic Oncology (2021)

Tianyi HuangMary K. TownsendRobert L. DoodAnil K. SoodShelley S. Tworoger

gynecologic oncologyantihypertensive medication usemedicinepharmacologyovarian cancerovarian cancer survival

Clinical Significance of Homologous Recombination Deficiency Score Testing in Endometrial Cancer. Gynecologic Oncology (2021)

gynecologic oncologypathologyrecombination dynamicvariant interpretationgynecologyclinical significancecancer researchmolecular diagnosticsendometrial cancergynecologic cancersoncology

1
2
3
4
10 / page

Similar Faculty Members

Bhavana Pothuri

Institution

New York University

gynecologic oncology

gynecology

Dineo Khabele, MD

Institution

Washington University in St. Louis

gynecologic oncology

chemotherapy resistance

Steven Plaxe

Institution

University of California, San Diego

oncology

gynecologic oncology

Lisa Barroilhet

Institution

University of Wisconsin–Madison

preventive medicine

public health

Nelson Teng

Institution

Stanford University

gynecologic oncology

gynecology

Victoria Bae-Jump

Institution

University of North Carolina at Chapel Hill

gynecologic oncology

oncology

Charles Landen

Institution

University of Virginia

ovarian cancer

gynecologic oncology

Rebecca Arend

Institution

University of Alabama at Birmingham

ovarian cancer

pathology

Barbara S. Norquist

Institution

University of Washington

telehealth

gynecology

Similar Faculty Members

Bhavana Pothuri

Institution

New York University

gynecologic oncology

gynecology

Dineo Khabele, MD

Institution

Washington University in St. Louis

gynecologic oncology

chemotherapy resistance

Steven Plaxe

Institution

University of California, San Diego

oncology

gynecologic oncology

Lisa Barroilhet

Institution

University of Wisconsin–Madison

preventive medicine

public health

Nelson Teng

Institution

Stanford University

gynecologic oncology

gynecology

Victoria Bae-Jump

Institution

University of North Carolina at Chapel Hill

gynecologic oncology

oncology

Charles Landen

Institution

University of Virginia

ovarian cancer

gynecologic oncology

Rebecca Arend

Institution

University of Alabama at Birmingham

ovarian cancer

pathology

Barbara S. Norquist

Institution

University of Washington

telehealth

gynecology